Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia

NCT03610321 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Gefarnate
DRUG: Statin

Sponsor

First Affiliated Hospital of Harbin Medical University